Cabot Announces Fourth Quarter Operating Results

October 27, 2004
EPS $0.23 versus $0.40 and Fiscal Year EPS $1.82 versus $1.14

BOSTON, Oct. 27 /PRNewswire-FirstCall/ -- Cabot Corporation (CBT/NYSE) today announced earnings of $15 million ($0.23 per diluted common share) for the fourth quarter ended September 30, 2004, compared with $28 million ($0.40 per diluted common share) for the year ago quarter. These results include $11 million ($0.16 per diluted common share) of after tax charges from certain items and discontinued operations in the fourth quarter ended September 30, 2004, compared with $2 million ($0.02 per diluted common share) of after tax income from certain items and discontinued operations for the same quarter of fiscal year 2003. For the fiscal year ended September 30, 2004, the Company earned $124 million ($1.82 per diluted common share) compared with $80 million ($1.14 per diluted common share) for the prior year. The full year results included $14 million ($0.20 per diluted common share) of after tax charges for certain items and discontinued operations, compared with $47 million ($0.67 per diluted common share) of after tax charges from certain items and discontinued operations for the prior year. Included in the fourth quarter and fiscal year 2004 certain items is a previously announced impairment charge of approximately $12 million related to the Company's investment in Sons of Gwalia. Additionally, the Company recorded a tax charge of $4 million due to the uncertain realization of a tax asset. This asset and the related impairment charge of $21 million for Sons of Gwalia were previously recorded in the third quarter of fiscal year 2003. With the charge taken in the current quarter, the Company has now completely written off its investment in Sons of Gwalia. Further details concerning charges from certain items and discontinued operations, which are not included in the business segment results discussed later in this release, are included in Exhibit I to this press release.

Kennett F. Burnes, Cabot's Chairman and CEO, said, "We are pleased to report strong earnings for the Company for fiscal year 2004 across all businesses. These results were driven by the success of numerous initiatives in both our core and developing businesses as well as continued cost improvements and an improved economic environment."

Burnes continued, "The Chemical Business rebounded from a difficult fiscal year 2003. Improved market conditions, new contracts with existing customers and cost improvements led to improved earnings in carbon black and fumed metal oxides. The Supermetals Business was successful in recovering from the expiration of the intermediate product portion of a customer contract at the end of fiscal year 2003 and also succeeded in extending contracts with two large customers. The Specialty Fluids Business performed very well due to an increase in the number and size of jobs completed during the year. We also achieved our targeted cost savings across the Company resulting from our "excellence" program which we began implementing last year to improve our overall operating performance."

Fourth Quarter Comparisons

Chemical Business -- For the quarter ended September 30, 2004, the Chemical Business segment had 9% volume growth and reported a 55% increase in year over year segment profit, from $11 million in the fourth quarter of fiscal year 2003 to $17 million in the fourth quarter of fiscal year 2004. Within the Chemical Business segment, carbon black's profit was equal to the fourth quarter last year. Volumes increased by 9% and costs were slightly down. However, this was offset by the earnings impact of inventory changes between periods. While the fiscal year 2003 quarterly results included costs related to decreases in inventory levels, a greater inventory decline and the related earnings impact occurred in the current quarter. Sequentially, profit declined by $28 million due primarily to a combination of seasonal business factors, including lower volumes and the cost of planned maintenance shutdowns. The decline was also caused by reduced margins resulting from increased raw material prices as well as the impact of changes in inventory, as noted above.

In the fourth quarter, profits in Cabot's fumed metal oxides business were $6 million higher than the same quarter last year due mainly to volume growth and improved product mix. Sequentially, although volumes remained strong, profits were $2 million lower primarily due to planned maintenance costs and the timing of other operating costs.

During the fourth quarter, the inkjet colorants business continued to deliver strong growth in the OEM and after-market segments. Sales volumes for this business were 56% higher in the fourth quarter of fiscal 2004 than in the same quarter last year, and 10% higher sequentially. Profits improved significantly compared to the fourth quarter of fiscal 2003.

Supermetals Business -- In the fourth quarter of fiscal 2004, the Cabot Supermetals Business earned $22 million of segment profit, which represents a $5 million decrease in segment profit compared to the same period of 2003. This decrease reflects lower sales of intermediate products offset in part by higher volumes in other product areas. In addition, the business sold a greater proportion of its capacitor products at market prices rather than at fixed contract prices during the quarter. Both operating and administrative costs improved compared with the same period last year. Sequentially, segment profit was $4 million higher than the third quarter of 2004 mainly due to higher volumes and lower operating costs offset partly by a shift in mix toward greater market price sales.

Specialty Fluids Business -- In the fourth quarter of fiscal 2004, Cabot Specialty Fluids completed nine jobs, most of which were begun in the third quarter. Segment profit was $4 million more than in the fourth quarter of 2003 due to the increased activity. Sequentially, segment profit was $5 million more than the prior quarter, reflecting the completion of a greater number of jobs in the current quarter.

Fiscal Year Comparisons

For the fiscal year ended September 30, 2004, Cabot reported revenues of $1.934 billion compared to $1.795 billion for 2003. The year over year revenue increase was primarily due to higher volumes in the Chemical Business and favorable translation of foreign revenues, offset partially by lower sales of intermediate products in Supermetals as well as unfavorable mix in Chemicals and greater non-contracted volumes in the Supermetals Businesses.

In fiscal 2004, Cabot earned $124 million of net income as compared to $80 million in 2003. The Chemical Business reported a $44 million increase in segment profit, driven primarily by higher volumes and lower operating costs offset partly by regional and product mix which resulted in lower average pricing. In addition, while fiscal year 2003 results benefited from the cost impact of increased inventories during the year, this benefit reversed in fiscal year 2004 as inventories declined. The Supermetals Business profit decreased by $31 million due to the absence of intermediate product sales partially offset by higher sales of other products and lower operating costs. The Specialty Fluids Business reported segment profit of $6 million, compared to a loss of $2 million in the prior year, due to an increase in both the number and size of wells using cesium formate during the year.

Outlook

With respect to the future, Burnes said, "We view these results as another solid step in our efforts to improve our operating performance and we are encouraged by the outlook for fiscal year 2005. In carbon black, we anticipate continued strong volumes and we are working to manage our margins in the face of high raw material costs. We are also executing our strategy of geographic migration as many of our customers move their manufacturing to emerging, lower cost regions. In fumed metal oxides, we expect continued strong demand, with our plants running at near capacity levels, and are pursuing our market development and capacity expansion plans in China. In Supermetals we are working to improve our cost competitiveness as sales transition from fixed contract prices to market based prices. Concerning our new businesses, in inkjet we continue to be very excited about the strength of our chemically treated pigment technology and its ability to enhance the quality and capability of inkjet printing. This technology will require our continued investment in research and development as well as manufacturing capability. In Specialty Fluids we are focusing our efforts on being the drilling fluid of choice in North Sea high pressure, high temperature wells and expanding our presence in other geographic areas, including the Gulf of Mexico and Saudi Arabia. We continue to invest cash and intellectual resources to develop our aerogels business and new business opportunities applying the SMP technology platforms and core competencies. We are monitoring these activities closely and are pleased with our continued progress in developing a robust new product pipeline. Given all of this, I am very optimistic about the long-term prospects for the Company."

For those interested in more detailed information on Cabot's Fourth Quarter and Fiscal Year 2004 results, please see the Supplemental Business Information available today on the Company's website in the Investor Relations section: http://w3.cabot-corp.com/earnings.cfm.

Cabot Corporation is a global specialty chemicals and materials company headquartered in Boston, MA. Cabot's major products are carbon black, fumed silica, inkjet colorants, capacitor materials, and cesium formate drilling fluids.

Forward-Looking Information: Included above are forward-looking statements relating to management's expectations regarding future profits, new business growth, the Company's product development program and the possible achievement of the Company's financial goals. Actual results may differ materially from the results anticipated in the forward-looking statements included in this press release due to a variety of factors, including domestic and global economic conditions, such as market supply and demand, prices and costs and availability of raw materials; fluctuations in currency exchange rates; patent rights of others; stock market conditions; the timely commercialization of products under development by the Company (which may be disrupted or delayed by technical difficulties, market acceptance, competitors' new products, as well as difficulties in moving from the experimental stage to the production stage); the Company's ability to successfully manage acquisitions; demand for our customers' products; competitors' reactions to market conditions; the accuracy of the assumptions used by the Company in establishing a reserve for its share of liability for respirator claims; and the outcome of pending litigation and governmental investigations. Other factors and risks are discussed in the Company's 2003 Annual Report on Form 10-K.

    Contact:
     James P. Kelly
     Director, Investor Relations
     (617) 342-6244



    CABOT CORPORATION SUMMARY RESULTS BY SEGMENTS


                                             Three Months      Twelve Months
    Periods ended September 30
    Dollars in millions, except per
     share amounts (unaudited)              2004     2003      2004      2003

    SALES

    Chemical Business                       $398     $345    $1,546    $1,371

    Supermetals Business                      80       96       338       390

    Specialty Fluids                          13        5        27        15

       Segment sales (A)                     491      446     1,911     1,776

    Unallocated and other (B)                  5        5        23        19

       Net sales and other operating
        revenues                            $496     $451    $1,934    $1,795

    SEGMENT PROFIT (LOSS)

    Chemical Business                        $17      $11      $132       $88

    Supermetals Business                      22       27        77       108

    Specialty Fluids                           5        1         6        (2)

       Total Segment Profit (C)               44       39       215       194

    Interest expense                          (8)      (7)      (30)      (28)

    General unallocated income (expense)
     (D)                                     (15)       2       (15)      (67)

    Less: Equity in net income of
     affiliated companies, net of tax         (1)      (2)       (6)       (5)

    Income from continuing operations
     before income taxes                      20       32       164        94

    Provision for income taxes                (5)      (7)      (39)      (17)

    Equity in net income of affiliated
     companies, net of tax                     1        2         6         5

    Minority interest in net income, net
     of tax                                   (2)      (1)       (9)       (7)

    Net income from continuing
     operations                               14       26       122        75

    Discontinued operations:

    Income from operations of
     discontinued businesses, net of tax
     (E)                                       1        2         2         5

    Net income                                15       28       124        80

    Dividends on preferred stock              (1)      (1)       (3)       (3)

    Net income available to common
     shares                                  $14      $27      $121       $77


    Diluted earnings per share of common
     stock
        Net income from continuing
         operations                        $0.21    $0.38     $1.79     $1.08

        Income from operations of
         discontinued businesses (E)       $0.02    $0.02     $0.03     $0.06

           Net income                      $0.23    $0.40     $1.82     $1.14

    Weighted average common shares
     outstanding

        Diluted (F)                           68       70        68        70


    (A) Segment sales for certain operating segments within the Chemical
        Business include 100% of sales of one equity affiliate and transfers
        of materials at cost and at market-based prices.

    (B) Unallocated and other reflects an elimination for sales of one equity
        affiliate offset by royalties paid by equity affiliates and external
        shipping and handling costs.

    (C) Segment profit is a measure used by Cabot's operating decision-makers
        to measure consolidated operating results and assess segment
        performance.  Segment profit includes equity in net income of
        affiliated companies, royalties paid by equity affiliates, minority
        interest and allocated corporate costs.

    (D) General unallocated income (expense) includes foreign currency
        transaction gains (losses), interest income, dividend income,
        and the certain items listed in Exhibit I.

    (E) Income related to recoveries from discontinued businesses, net of tax.

    (F) Commencing in Fiscal 2004, Cabot has adjusted its calculation of fully
        diluted shares outstanding to reflect the number of shares the
        Company could repurchase with the assumed proceeds from restricted
        stock awards under the Company's Long Term Incentive Program.
        Prior periods have not been adjusted because the adjustment would not
        have been material.


    CABOT CORPORATION CONSOLIDATED STATEMENTS OF OPERATIONS


                                             Three Months     Twelve  Months
    Periods ended September 30
    Dollars in millions, except per
     share amounts (unaudited)              2004     2003      2004      2003


    Net sales and other operating
     revenues                               $496     $451    $1,934    $1,795

    Cost of sales                            386      372     1,457     1,373

           Gross profit                     $110      $79      $477      $422


    Selling and administrative expenses       52       63       217       251

    Research and technical expenses           14       13        53        64

        Income from operations               $44       $3      $207      $107


    Other income and expense

        Interest and dividend income           2        1         6         5

        Interest expense                      (8)      (7)      (30)      (28)

        Other income (expense)               (18)      35       (19)       10

           Total other income and
            expense                          (24)      29       (43)      (13)


    Income from continuing operations
     before income taxes                      20       32       164        94


    Provision for income taxes                (5)      (7)      (39)      (17)

    Equity in net income of affiliated
     companies, net of tax                     1        2         6         5

    Minority interest in net income, net
     of tax                                   (2)      (1)       (9)       (7)


    Net income from continuing
     operations                               14       26       122        75


    Discontinued operations:
    Income from operations of
     discontinued businesses, net of tax(A)    1        2         2         5


    Net income                                15       28       124        80

    Dividends on preferred stock              (1)      (1)       (3)       (3)

    Net income available to common
     shares                                  $14      $27      $121       $77

    Diluted earnings per share of common
     stock
        Net income from continuing
         operations                        $0.21    $0.38     $1.79     $1.08

        Income from operations of
         discontinued businesses (A)       $0.02    $0.02     $0.03     $0.06

           Net income                      $0.23    $0.40     $1.82     $1.14

    Weighted average common shares
     outstanding

        Diluted(B)                            68       70        68        70

     (A) Income related to recoveries from
         discontinued businesses, net of tax.
     (B) Commencing in Fiscal 2004, Cabot has adjusted
         its calculation of fully diluted shares outstanding to reflect
         the number of shares the Company could repurchase with the
         assumed proceeds from restricted stock awards under the
         Company's Long Term Incentive Program. Prior periods
         have not been adjusted because the adjustment would not have
         been material.


    CABOT CORPORATION CONDENSED CONSOLIDATED FINANCIAL POSITION


                                                September 30,    September 30,
                                                      2004             2003
    In millions                                   (unaudited)

    Current assets                                   $1,173           $1,111

    Net property, plant and equipment                   918              913

    Other non-current assets                            335              284

              Total assets                           $2,426           $2,308


    Current liabilities                                $342             $352

    Non-current liabilities                             893              877

    Stockholders' equity                              1,191            1,079

              Total liabilities and
               stockholders' equity                  $2,426           $2,308

    Working capital                                    $831             $759



    CABOT CORPORATION

                                                Fiscal 2003
    In millions, except per
     share amounts (unaudited)     Dec. Q. Mar. Q. June Q. Sept. Q.  FY

    Sales
    Chemical Business               $309   $352     $366    $345  $1,371
    Supermetals Business              96    107       92      96     390
    Specialty Fluids                   2      3        6       5      15
      Segment Sales (A)              407    462      464     446   1,776
    Unallocated and other (B)          3      4        4       5      19

    Net sales and other
     operating revenues             $410   $466     $468    $451  $1,795

    Segment Profit (Loss)
    Chemical Business                $24    $23      $30     $11     $88
    Supermetals Business              32     36       14      27     108
    Specialty Fluids                  (1)    (1)      (1)      1      (2)
    Total segment profit (loss) (C)   55     58       43      39     194

    Income (Loss) Available to Common Shares
    Interest expense                  (7)    (7)      (7)     (7)    (28)
    General unallocated
     income (expense) (D)             (2)   (20)     (48)      2     (67)
    Less: Equity in net income
     of affiliated companies,
     net of tax                       (1)    (1)      (2)     (2)     (5)

    Income (Loss) from Continuing
     Operations before income taxes   45     30      (14)     32      94
    (Provision) benefit
     for income taxes                (11)    (6)       6      (7)    (17)
    Equity in net income of
     affiliated companies,
     net of tax                        1      1        2       2       5
    Minority interest in net
     income, net of tax               (2)    (2)      (2)     (1)     (7)

    Income (Loss) from
     Continuing Operations            33     23       (8)     26      75
    Discontinued Operations
    Income (Loss) from Operations
     of Discontinued Businesses,
     net of income taxes (E)           -      -        3       2       5

    Net income (loss)                 33     23       (5)     28      80
    Dividends on preferred stock      (1)    (1)       -      (1)     (3)

    Net income (loss) available
     to common shares                $32    $22      ($5)    $27     $77

    Income (Loss) per common share
    Net income (loss) from
     Continuing Operations         $0.48  $0.33   $(0.14)  $0.38   $1.08
    Income (Loss) from
     Operations of Discontinued
     Businesses (E) (F)                -      -     0.05    0.02    0.06
    Total                          $0.48  $0.33   $(0.09)  $0.40   $1.14
    Weighted average common
     shares outstanding
    Diluted (G)                       70     70       59      70      70


    CABOT CORPORATION
                                                Fiscal 2004
    In millions, except per
     share amounts (unaudited)     Dec. Q. Mar. Q. June Q. Sept. Q.  FY

    Sales
    Chemical Business               $351   $399     $398    $398  $1,546
    Supermetals Business              87     85       86      80     338
    Specialty Fluids                   1      9        4      13      27
    Segment Sales (A)                439    493      488     491   1,911
    Unallocated and other (B)          7      7        4       5      23

    Net sales and other
     operating revenues             $446   $500     $492    $496  $1,934

    Segment Profit (Loss)
    Chemical Business                $27    $43      $45     $17    $132
    Supermetals Business              21     16       18      22      77
    Specialty Fluids                  (2)     3        -       5       6
    Total segment profit (loss) (C)   46     62       63      44     215

    Income (Loss) Available to Common Shares
    Interest expense                  (7)    (7)      (8)     (8)    (30)
    General unallocated
     income (expense) (D)              -     (3)       2     (15)    (15)
    Less: Equity in net income
     of affiliated companies,
     net of tax                       (2)    (1)      (2)     (1)     (6)

    Income (Loss) from Continuing
     Operations before income taxes   37     51       55      20     164
    (Provision) benefit for
     income taxes                     (8)   (13)     (13)     (5)    (39)
    Equity in net income of
     affiliated companies,
     net of tax                        2      1        2       1       6
    Minority interest in net
     income, net of tax               (1)    (3)      (3)     (2)     (9)

    Income (Loss) from
     Continuing Operations            30     36       41      14     122
    Discontinued Operations
    Income (Loss) from Operations
     of Discontinued Businesses,
     net of income taxes (E)          (1)     1        1       1       2

    Net income (loss)                 29     37       42      15     124
    Dividends on preferred stock      (1)    (1)       -      (1)     (3)

    Net income (loss) available
     to common shares                $28    $36      $42     $14    $121

    Income (Loss) per common share
    Net income (loss) from
     Continuing Operations         $0.43  $0.53    $0.61   $0.21   $1.79
    Income (Loss) from
     Operations of Discontinued
     Businesses (E) (F)            (0.01)  0.01     0.01    0.02    0.03
    Total                          $0.42  $0.54    $0.62   $0.23   $1.82
    Weighted average common
     shares outstanding
    Diluted (G)                       68     69       69      68      68

    (A) Segment sales for certain operating segments within the Chemical
        Business include 100% of sales of one equity affiliate and transfers
        of materials at cost and at market-based prices.
    (B) Unallocated and other reflects an elimination for sales for one equity
        affiliate offset by royalties paid by equity affiliates and external
        shipping and handling costs.
    (C) Segment profit is a measure used by Cabot's operating decision-makers
        to measure consolidated operating results and assess segment
        performance.  Segment profit includes equity in net income of
        affiliated companies, royalties paid by equity affiliates, minority
        interest and allocated corporate costs.
    (D) General unallocated income (expense) includes foreign currency
        transaction gains (losses), interest income, dividend income and
        certain items.
    (E) Additional income in Fiscal 2003, Q3 2004, and Q4 2004 related to
        recoveries from discontinued businesses, net of tax.
    (F) Amounts in Q1 2004 and Q2 2004 relate to litigation associated with a
        previously divested business, net of tax.
    (G) Commencing in Fiscal 2004, Cabot has adjusted its calculation of
        fully diluted shares outstanding to reflect the number of shares the
        Company could repurchase with the assumed proceeds from restricted
        stock awards under the Company's Long Term Incentive Program.  Prior
        periods have not been adjusted because the adjustment would not have
        been material.


    CABOT CORPORATION  CERTAIN ITEMS - Exhibit I

    Periods ended September 30                      Three Months
    Dollars in millions, except per
     share amounts (unaudited)           2004        2004    2003      2003
                                          $       per share   $   per share
    Certain items before income taxes

    Investment impairment charges        $(12)      $(0.17)    $-     $-

    Reserve for respirator claims           2         0.02      -      -

    Restructuring initiatives              (2)       (0.02)   (33)    (0.36)

    Insurance recoveries                    -         -         2      0.02

    In-process research and development     -         -         -      -

    Asset impairment charges                -         -        (4)    (0.04)

    Sale of equity interest                 -         -        35      0.38

    Other non-operating items              (1)       (0.01)     -      -

    Total certain items                   (13)       (0.18)     -      0.00


    Discontinued operations                 1         0.02      3      0.02

    Total certain items and
     discontinued operations pre-tax      (12)       (0.16)     3      0.02


    Total certain items and discontinued
     operations after tax                $(11)      $(0.16)    $2     $0.02


    Periods ended September 30                    Twelve Months
    Dollars in millions, except per
     share amounts (unaudited)           2004        2004    2003      2003
                                          $       per share   $   per share
    Certain items before income taxes

    Investment impairment charges        $(12)      $(0.17)  $(22)   $(0.21)

    Reserve for respirator claims           2         0.02    (20)    (0.22)

    Restructuring initiatives              (6)       (0.06)   (51)    (0.55)

    Insurance recoveries                    -         -         4      0.04

    In-process research and development     -         -       (14)    (0.13)

    Asset impairment charges                -         -        (4)    (0.04)

    Sale of equity interest                 -         -        35      0.38

    Other non-operating items              (2)       (0.02)     -      -

    Total certain items                   (18)       (0.23)   (72)    (0.73)



    Discontinued operations                 2         0.03      7      0.06

    Total certain items and
     discontinued operations pre-tax      (16)       (0.20)   (65)    (0.67)


    Total certain items and discontinued
     operations after tax                $(14)      $(0.20)  $(47)   $(0.67)




    Periods ended September 30           Three Months       Twelve Months
    Dollars in millions, except per share
     amounts (unaudited)                 2004   2003        2004    2003

    Statement of Operations Line Item

    Cost of sales                          (2)   (29)         (5)    (40)

    Selling and administrative expenses     3     (5)          2     (31)

    Research and technical service          -     (1)          -     (14)

    Other (charges) income                (14)    35         (15)     13

    Total certain items                   (13)     -         (18)    (72)

To access a copy of the Supplemental Business Information for this quarter please Click here.